> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-136/
- Published: 2017-06-11T12:00:00.000Z
- Updated: 2026-09-14T22:28:36.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5138848

[**Pediatric Oncology Meeting Planned for 6/21-22**](https://www.fdaweb.com/pediatric-oncology-meeting-planned-for-6-21-22/)  
Federal Register notice: FDA announces a 6/21-22 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee meeting.  
06/8/2017

[**FDA Vaccines Panel Meeting to Review Hep B Vaccine**](https://www.fdaweb.com/fda-vaccines-panel-meeting-to-review-hep-b-vaccine/)  
Federal Register notice: FDA announces a 7/28 Vaccines and Related Biological Products Advisory Committee meeting that will vote on a Hepatitis B Vaccine manufactured by Dynavax.  
06/8/2017

[**Comments on Criteria for OTC Drugs Seen as GRASE**](https://www.fdaweb.com/comments-on-criteria-for-otc-drugs-seen-as-grase/)  
Federal Register notice: FDA seeks comments on an information collection revision to “Additional Criteria and Procedures for Classifying Over- the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded.”  
06/7/2017

[**Comments Sought on eSubmitted Allegations to CDRH**](https://www.fdaweb.com/comments-sought-on-esubmitted-allegations-to-cdrh/)  
Federal Register notice: FDA seeks comments on an information collection extension for “Electronic Submission Process for Voluntary Allegations to the Center for Devices and Radiological Health.”  
06/7/2017